A Novel Dietary-Related Model of Esophagitis and Barrett's Esophagus, a Premalignant Lesion
暂无分享,去创建一个
A. Bhattacharyya | H. Bernstein | H. Garewal | C. Payne | C. Bernstein | K. Dvorak | H. Holubec | Naihsuan C. Guy
[1] A. Baldwin,et al. THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .
[2] A. Keshavarzian,et al. Reactive oxygen species: are they involved in the pathogenesis of GERD, barrett's esophagus, and the latter's progression toward esophageal cancer? , 2002, American Journal of Gastroenterology.
[3] T. Hattori,et al. Immunohistochemical analysis of short‐segment Barrett's esophagus , 2004, Journal of gastroenterology and hepatology.
[4] H. Çelik,et al. Effect of omeprazole on plasma zinc levels after oral zinc administration. , 2002, Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology.
[5] F. Bosman,et al. Nuclear accumulation of beta-catenin is a common and early event during neoplastic progression of Barrett esophagus. , 2000, American journal of clinical pathology.
[6] R. Sampliner,et al. A bile acid-induced apoptosis assay for colon cancer risk and associated quality control studies. , 1999, Cancer research.
[7] M. Monden,et al. Beta-catenin expression in human cancers. , 1996, The American journal of pathology.
[8] J. Peters,et al. Suppression of gastric acid secretion in patients with gastroesophageal reflux disease results in gastric bacterial overgrowth and deconjugation of bile acids , 2007, Journal of Gastrointestinal Surgery.
[9] J. Beynon,et al. Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity , 1999, Gut.
[10] G. Triadafilopoulos,et al. Acid- and bile-induced PGE2 release and hyperproliferation in Barrett's esophagus are COX-2 and PKC-ε dependent , 2002 .
[11] J. Dekker,et al. Gastric‐type mucin and TFF‐peptide expression in Barrett's oesophagus is disturbed during increased expression of MUC2 , 2003, Histopathology.
[12] Y. Doki,et al. Cytoplasmic β‐catenin in esophageal cancers , 1999 .
[13] F. Real,et al. Differential apomucin expression in normal and neoplastic human gastrointestinal tissues. , 1994, Gastroenterology.
[14] H Feussner,et al. Composition and concentration of bile acid reflux into the esophagus of patients with gastroesophageal reflux disease. , 1997, Surgery.
[15] M. Klein,et al. Phenotype of columnar-lined esophagus in rats with esophagogastroduodenal anastomosis: similarity to human Barrett's esophagus , 2004, Laboratory Investigation.
[16] P. Dítě,et al. [Barrett's esophagus]. , 2000, Bratislavske lekarske listy.
[17] J. Reynolds,et al. Proinflammatory Cytokine and Nuclear Factor Kappa-B Expression along the Inflammation–Metaplasia–Dysplasia–Adenocarcinoma Sequence in the Esophagus , 2005, The American Journal of Gastroenterology.
[18] B. Ames,et al. Low intracellular zinc induces oxidative DNA damage, disrupts p53, NFκB, and AP1 DNA binding, and affects DNA repair in a rat glioma cell line , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[19] C. Croce,et al. p53 deficiency accelerates induction and progression of esophageal and forestomach tumors in zinc-deficient mice. , 2003, Cancer research.
[20] T. Jang,et al. Expression of Inducible Nitric Oxide Synthase Is Increased in Rat Barrett's Esophagus Induced by Duodenal Contents Reflux , 2005, Journal of Korean medical science.
[21] G. Cotter,et al. Effects of captopril and enalapril on zinc metabolism in hypertensive patients. , 1998, Journal of the American College of Nutrition.
[22] W. Maret,et al. Zinc requirements and the risks and benefits of zinc supplementation. , 2006, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements.
[23] R. Sampliner,et al. Abnormal Expression of Biomarkers in Incompletely Ablated Barrett’s Esophagus , 2006, Annals of surgery.
[24] Z. Kelman. PCNA: structure, functions and interactions , 1997, Oncogene.
[25] Y. Doki,et al. Cytoplasmic beta-catenin in esophageal cancers. , 1999, International journal of cancer.
[26] Robert C. G. Martin,et al. Esophageal injury with external esophageal perfusion. , 2005, The Journal of surgical research.
[27] H. Steininger,et al. Expression of CDX2 and MUC2 in Barrett's mucosa. , 2005, Pathology, research and practice.
[28] H. Bernstein,et al. Bile acids as carcinogens in human gastrointestinal cancers. , 2005, Mutation research.
[29] J. Hagen,et al. The impact of reflux composition on mucosal injury and esophageal function , 2006, Journal of Gastrointestinal Surgery.
[30] J. Reynolds,et al. NF-&kgr;B Activation in Esophageal Adenocarcinoma: Relationship to Barrett's Metaplasia, Survival, and Response to Neoadjuvant Chemoradiotherapy , 2004, Annals of surgery.
[31] A. Cameron,et al. Epidemiology of columnar-lined esophagus and adenocarcinoma. , 1997, Gastroenterology clinics of North America.
[32] J. Beckman. Oxidative damage and tyrosine nitration from peroxynitrite. , 1996, Chemical research in toxicology.
[33] Steffen Mühldorfer,et al. Activation of NFκB Represents the Central Event in the Neoplastic Progression Associated with Barrett's Esophagus: A Possible Link to the Inflammation and Overexpression of COX-2, PPARγ and Growth Factors , 2004, Digestive Diseases and Sciences.
[34] R. Sampliner,et al. Bile acids in combination with low pH induce oxidative stress and oxidative DNA damage: relevance to the pathogenesis of Barrett’s oesophagus , 2006, Gut.
[35] J. Fraumeni,et al. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States , 1998, Cancer.
[36] G. Jenkins,et al. The bile acid deoxycholic acid (DCA) at neutral pH activates NF-kappaB and induces IL-8 expression in oesophageal cells in vitro. , 2003, Carcinogenesis.
[37] H. Bernstein,et al. Mitochondrial perturbation attenuates bile acid-induced cytotoxicity , 2005, Cell Biology and Toxicology.
[38] R. Mancini,et al. Combined Cyclin D 1 Overexpression and Zinc Deficiency Disrupts Cell Cycle and Accelerates Mouse Forestomach Carcinogenesis 1 , 2003 .
[39] C. Wild,et al. Risk Factors, DNA Damage, and Disease Progression in Barrett's Esophagus , 2005, Cancer Epidemiology Biomarkers & Prevention.
[40] F. Bosman,et al. Beta-catenin expression and its association with prognostic factors in adenocarcinoma developed in Barrett esophagus. , 2002, American journal of clinical pathology.
[41] A. Lindgren,et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. , 1999, The New England journal of medicine.
[42] H. Barr,et al. Altered cadherin and catenin complexes in the Barrett's esophagus-dysplasia-adenocarcinoma sequence: correlation with disease progression and dedifferentiation. , 1998, The American journal of pathology.
[43] S. Spechler,et al. Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus. , 2002, Gastroenterology.
[44] J. Jankowski,et al. Barrett's metaplasia , 2000, The Lancet.
[45] D. Weisenburger,et al. Nutrient Intakes and Adenocarcinoma of the Esophagus and Distal Stomach , 2002, Nutrition and cancer.
[46] A. Baldwin,et al. The NF-kappa B and I kappa B proteins: new discoveries and insights. , 1996, Annual review of immunology.
[47] J. Pandolfino,et al. Obesity: a challenge to esophagogastric junction integrity. , 2006, Gastroenterology.
[48] M. Yılmaz,et al. Increased oxidative stress and hypozincemia in male obesity. , 2002, Clinical biochemistry.
[49] Ananda S. Prasad,et al. Zinc in Cancer Prevention , 2009, Nutrition and cancer.
[50] Webb Jl. Nutritional effects of oral contraceptive use: a review. , 1980 .
[51] Á. Lanas,et al. Free radicals and antioxidant systems in reflux esophagitis and Barrett's esophagus. , 2005, World journal of gastroenterology.
[52] Á. Lanas,et al. Superoxide Anion and Nitric Oxide in High-Grade Esophagitis Induced by Acid and Pepsin in Rabbits , 2001, Digestive Diseases and Sciences.
[53] K. Hahm,et al. Oxidative damages are critical in pathogenesis of reflux esophagitis: implication of antioxidants in its treatment. , 2001, Free radical biology & medicine.
[54] M F Dixon,et al. Bile reflux gastritis and Barrett's oesophagus: further evidence of a role for duodenogastro-oesophageal reflux? , 2001, Gut.
[55] W. Leary,et al. Urinary zinc excretion, diuretics, zinc deficiency and some side-effects of diuretics. , 1983, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.
[56] H. Sandstead. Understanding zinc: recent observations and interpretations. , 1994, The Journal of laboratory and clinical medicine.
[57] J. Reynolds,et al. Low pH induces co-ordinate regulation of gene expression in oesophageal cells. , 2006, Carcinogenesis.
[58] E. Hahn,et al. Activation of NFkappaB represents the central event in the neoplastic progression associated with Barrett's esophagus: a possible link to the inflammation and overexpression of COX-2, PPARgamma and growth factors. , 2004, Digestive diseases and sciences.
[59] G. Triadafilopoulos,et al. Acid- and bile-induced PGE(2) release and hyperproliferation in Barrett's esophagus are COX-2 and PKC-epsilon dependent. , 2002, American journal of physiology. Gastrointestinal and liver physiology.
[60] Robert C. G. Martin,et al. Esophageal Injury with External Esophageal Perfusion1 , 2005 .